Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops
Bristol Myers Squibb (NYSE: BMY) reported net profit for the first quarter of 2025, compared to a loss last year. The biotechnology company’s revenues declined 6% in Q1. Net income attributable to shareholders was $2.46 million or $1.20 per share in the March quarter, compared to a loss of $11.9 billion or $5.89 per share … Read more